dockets: DEA-2023-0149

Regulatory dockets from Regulations.gov — containers for related documents and comments in a rulemaking proceeding.

This data as json

id	agency_id	title	docket_type	last_modified	object_id	rin	dkabstract	category	subtype	keywords	program	short_title	effective_date	organization	attrs_raw	attr_source
DEA-2023-0149	DEA	Placement of Zuranolone in Schedule IV (DEA1258)	Rulemaking	2024-09-03T18:47:04Z	0b000064861a0975	Not Assigned	This rule places zuranolone (chemically known as 1-[2- [(3R,5R,8R,9R,10S,13S,14S,17S)-3- hydroxy-3,13-dimethyl2,4,5,6,7,8,9,10,11,12,14,15,16,17- tetradecahydro-1Hcyclopenta[a]phenanthren-17-yl]-2- oxoethyl]pyrazole-4-carbonitrile) and its salts in schedule IV of the Controlled Substances Act.								{"displayProperties": [], "keywords": null, "modifyDate": "2024-09-03T18:47:04Z", "dkAbstract": "This rule places zuranolone (chemically known as 1-[2- [(3R,5R,8R,9R,10S,13S,14S,17S)-3- hydroxy-3,13-dimethyl2,4,5,6,7,8,9,10,11,12,14,15,16,17- tetradecahydro-1Hcyclopenta[a]phenanthren-17-yl]-2- oxoethyl]pyrazole-4-carbonitrile) and its salts in schedule IV of the Controlled Substances Act. ", "agencyId": "DEA", "program": null, "shortTitle": null, "subType2": null, "title": "Placement of Zuranolone in Schedule IV (DEA1258)", "generic": null, "field1": null, "docketType": "Rulemaking", "petitionNbr": null, "rin": "Not Assigned", "organization": null, "legacyId": null, "subType": null, "category": null, "field2": null, "effectiveDate": null, "objectId": "0b000064861a0975"}	single_get

Links from other tables